Pharsight®, a Certara™ company, is a market-leading provider of scientific consulting services and software products for improved productivity and strategic decision making in drug development. Established in 1995, our goal remains to help biotechnology and pharmaceutical companies reduce the time, cost and risk of drug development. With more than 1200 customers worldwide, Pharsight products and services are used by all of the world’s top 50 drug development organizations, and we have a rapidly growing base of small and mid-sized biotechnology customers.
Pharsight Consulting Services is the world’s most experienced group of scientific experts dedicated to supporting strategic drug development decisions and new drug sub-missions. Our team of more than 40 scientists provides a unique combination of experience, insight, and technical innovation in the disciplines of pharmacometrics, pharmacokinetic (PK) analysis and programming, biostatistics and medical writing. We conduct over 200 successful client engagements per year from pre-clinical to post-launch, collaborating with sponsors on quantitative analysis, modeling, and predictive simulation of diseases, drugs and clinical trials across all major therapeutic areas. The Pharsight consulting team leverages expertise in Pharsight’s leading software tools for PK/PD analysis, modeling and data management.